Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | ATM | Q13315 | 2/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.39 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.36 |
| ▸ | RELA | Q04206 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12033701 | 0.95 | KDM4E (0.36) | KDM4EATML3MBTL1PDE10AALDH1A1 | |
| SCHEMBL12033859 | 0.95 | KDM4E (0.36) | KDM4EATML3MBTL1PDE10AALDH1A1 | |
| SCHEMBL10059117 | 0.94 | KDM4E (0.35) | KDM4EATML3MBTL1PDE10AALDH1A1 | |
| SCHEMBL10059276 | 0.94 | KDM4E (0.40) | KDM4EATML3MBTL1ALDH1A1TP53 | |
| SCHEMBL10059265 | 0.94 | KDM4E (0.45) | KDM4EATML3MBTL1ALDH1A1TP53 | |
| SCHEMBL12034118 | 0.94 | KDM4E (0.45) | KDM4EATML3MBTL1ALDH1A1TP53 | |
| SCHEMBL15371765 | 0.93 | KDM4E (0.42) | KDM4EATML3MBTL1PDE10AALDH1A1 | |
| SCHEMBL12033689 | 0.93 | KDM4E (0.37) | KDM4EATML3MBTL1PDE10AALDH1A1 | |
| SCHEMBL23183686 | 0.92 | PDE10A (0.35) | KDM4EATML3MBTL1PDE10AALDH1A1 | |
| SCHEMBL15449725 | 0.92 | KDM4E (0.38) | KDM4EATML3MBTL1PDE10AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11316113-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2022-04-26 | — | — | US | disclosed |
| US-20190081246-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2019-03-14 | — | — | US | disclosed |
| US-9954180-B2 | Bicarbazole compounds for OLEDs | UNIVERSAL DISPLAY CORPORATION (US) | 2018-04-24 | — | — | US | disclosed |
| US-9954180-B2 | Bicarbazole compounds for OLEDs | UNIVERSAL DISPLAY CORPORATION (US) | 2018-04-24 | — | — | US | disclosed |
| US-20170170409-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2017-06-15 | — | — | US | disclosed |
| US-20170170409-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2017-06-15 | — | — | US | disclosed |
| US-20140131665-A1 | Organic Electroluminescent Device With Delayed Fluorescence | UNIVERSAL DISPLAY CORPORATION (US) | 2014-05-15 | — | — | US | disclosed |
| US-20140131665-A1 | Organic Electroluminescent Device With Delayed Fluorescence | UNIVERSAL DISPLAY CORPORATION (US) | 2014-05-15 | — | — | US | disclosed |
| US-20130140549-A1 | BICARBAZOLE COMPOUNDS FOR OLEDS | UNIVERSAL DISPLAY CORPORATION (US) | 2013-06-06 | — | — | US | disclosed |
| US-20130140549-A1 | BICARBAZOLE COMPOUNDS FOR OLEDS | UNIVERSAL DISPLAY CORPORATION (US) | 2013-06-06 | — | — | US | disclosed |
| WO-2012023947-A1 | BICARBAZOLE COMPOUNDS FOR OLEDS | UNIVERSAL DISPLAY CORPORATION (US) | 2012-02-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11316113-B2 | Organic electroluminescent materials and devices | TYMS, UMPS, TYMP | KDM4E 2651/4885ATM 1947/4885L3MBTL1 957/4885 |
| US-20190081246-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | TYMS, UMPS, TYMP | KDM4E 2651/4885ATM 1947/4885L3MBTL1 957/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.